Global Uterine Manipulation Devices Market - 2025-2033

The global uterine manipulation devices market reached US$ 293.7 million in 2024 and is expected to reach US$ 487.7 million by 2033, growing at a CAGR of 5.8% during the forecast period 2025-2033.

Uterine manipulation devices are specialized surgical instruments designed to assist gynecological surgeons in positioning, stabilizing, and mobilizing the uterus during various minimally invasive and open surgical procedures. These devices are particularly critical in laparoscopic, hysteroscopic and other gynecological surgeries, enabling precise uterine movement to enhance surgical access, visualization, and overall procedural efficiency. Uterine manipulators are available in single-use (disposable) models for enhanced sterility and reusable designs for cost-effectiveness, depending on clinical preferences.

The demand for uterine manipulation devices is driven by the increasing adoption of minimally invasive gynecological surgeries, a growing awareness of women's health issues and advancements in surgical technologies. For instance, according to the article publised by the ScienceDirect, a uterine manipulator is frequently utilized during a minimally invasive hysterectomy to improve access to the surgical field and serve as a landmark for colpotomy. Prior studies have indicated rates of uterine manipulator use between 42-90 % during minimally invasive surgeries for endometrial cancer.

Market Dynamics: Drivers & Restraints

Rising prevalence of gynecological disorders

The rising prevalence of gynecological disorders such as uterine fibroids, endometriosis and uterine cancer is significantly driving the growth of the uterine manipulation devices market and is expected to drive the market over the forecast period. As these conditions often require surgical intervention, the demand for effective tools, such as uterine manipulators, has risen.

According to the National Institute of Health (NIH), Uterine leiomyomas also known as fibroids, mostly afflict women throughout their reproductive years and are detected in up to 70% of white women and more than 80% of African-American women over their lifespan. Many women with fibroids undergo myomectomy (fibroid removal) or hysterectomy, both of which require uterine manipulation devices for optimal surgical outcomes, especially in minimally invasive procedures like laparoscopic surgeries.

For instance, according to the National Institute of Health (NIH), hysterectomy is one of the most common surgeries performed in women in the United States, totaling roughly 600,000 procedures each year, with approximately 10% of procedures being subtotal (cervix-preserving) and a significant number of these surgeries are due to fibroids, creating demand for uterine manipulators.

According to the World Health Organization (WHO), endometriosis affects roughly 10% (190 million) of reproductive-age women and girls globally, with a significant percentage requiring surgical intervention for symptom management or fertility preservation. Surgery for endometriosis often involves laparoscopy, during which uterine manipulation devices are used to reposition and stabilize the uterus, facilitating the removal of endometrial tissue.

Additionally, the American Cancer Society forecasts for cancer of the uterus in the United States in 2024 approximately 67,880 new cases of uterine cancer will be diagnosed. Treatment often involves hysterectomy or lymphadenectomy, where uterine manipulation devices assist in positioning the uterus for safer and more effective surgical removal.

Risk of device-related complications

The risk of device-related complications is expected to hamper the growth of the uterine manipulation devices market. Despite the advantages these devices offer in terms of precision and efficiency during surgical procedures, complications such as uterine perforation, infection, and improper device handling can lead to adverse outcomes, which may deter healthcare providers from adopting these devices.

Uterine perforation occurs when the manipulator tip inadvertently punctures the uterine wall, leading to significant complications such as bleeding, infection, and injury to surrounding organs. For instance, according to the study conducted by the National Institute of Health (NIH), the use of uterine manipulators and uterine perforation in minimally invasive endometrial cancer surgery study found a uterine perforation rate of 11%.

Infection is another concern when using uterine manipulation devices, particularly when the device is not properly sterilized or if the uterine cavity is contaminated during the procedure. For instance, according to a study in the American Journal of Obstetrics & Gynecology, surgical site infections occur in about 2-5% of laparoscopic surgeries. However, this rate can increase in the case of improper sterilization of surgical tools.

Segment Analysis

The global uterine manipulation devices market is segmented based on type, application, end-user and region.

Application:

The total laparoscopic hysterectomy (TLH) segment is expected to dominate the uterine manipulation devices market share

Total laparoscopic hysterectomy (TLH) is a minimally invasive surgical procedure used to remove the uterus, and it is the dominant segment in the uterine manipulation devices market. The increasing preference for TLH, due to its numerous advantages over traditional open surgery, such as reduced recovery time, lower risk of complications, and better cosmetic outcomes, has made it a key driver of demand for uterine manipulation devices.

The demand for uterine manipulation devices in TLH is particularly high because these devices enhance the precision of the surgery by stabilizing and positioning the uterus, which is vital for laparoscopic access. For instance, according to the American College of Obstetricians and Gynecologists, 70-80% of hysterectomies in the U.S. are now performed laparoscopically, with TLH being the preferred method, further driving the growth of uterine manipulation devices in this segment.

The adoption rate of TLH is growing due to its many advantages over abdominal hysterectomy, such as faster recovery time, less blood loss, and fewer post-operative complications. As more hospitals and clinics adopt TLH as the standard for hysterectomy, the use of uterine manipulation devices has correspondingly increased. For instance, in the U.S., TLH procedures increased by over 15% annually from 2010 to 2020, and this growth is expected to continue as TLH becomes the preferred method for hysterectomy worldwide.

Geographical Analysis

North America is expected to hold a significant position in the uterine manipulation devices market share

North America especially the United States performs hundreds of thousands of hysterectomies annually, the majority of which are now laparoscopic procedures. With TLH being the most common method, uterine manipulation devices are in high demand to ensure the success and precision of these surgeries. For instance, according to the National Institute of Health (NIH), hysterectomy is one of the most common surgeries performed in women in the United States, with 600,000 procedures each year.

North American medical device manufacturers are leaders in developing and improving uterine manipulation devices, incorporating advanced features such as better ergonomics, user-friendly interfaces, and enhanced safety features. This innovation attracts hospitals and surgical centers in the region to adopt these devices more frequently.

For instance, leading manufacturers in North America, like CooperSurgical, produce high-quality uterine manipulators that are widely used in TLH procedures across the region. The RUMI II manipulator is a notable example, widely adopted in U.S. hospitals for its advanced design and effectiveness in TLH.

Asia-Pacific is growing at the fastest pace in the uterine manipulation devices market

In Asia-Pacific, especially in Japan, China and India, laparoscopic surgery, including total laparoscopic hysterectomy, is becoming the preferred method for hysterectomy in the region due to its minimally invasive nature, which reduces recovery times and healthcare costs. As more surgeons and hospitals in the region adopt minimally invasive techniques, the demand for uterine manipulators, which are essential in laparoscopic procedures, has surged.

For instance, according to the National Institute of Health, in Japan, over 50% of hysterectomies are now performed laparoscopically, and this trend is rapidly growing across other APAC nations. In China, laparoscopic hysterectomy adoption rates have increased by 18-20% annually over the past decade.

The Asia-Pacific region is becoming a global hub for medical tourism, with countries like Thailand, India, and Malaysia attracting patients for affordable, high-quality medical procedures. Many of these patients undergo laparoscopic surgeries, which require uterine manipulation devices. The increase in surgical volume, driven by medical tourism and local patients, boosts the demand for uterine manipulators, particularly in countries with established medical tourism industries.

Competitive Landscape

The major global players in the uterine manipulation devices market include B. Braun Melsungen AG, CONMED Corporation, CooperSurgical Inc., Normedi, a Hologic Company, KARL STORZ SE & Co. KG, Conkin Surgical Instrument Ltd., Richard Wolf GmbH, Purple Surgical, Utah Medical Products, Inc., LABORIE MEDICAL TECHNOLOGIES CORP. and among others.

Why Purchase the Report?

• Pipeline & Innovations: Reviews ongoing clinical trials, product pipelines, and forecasts upcoming advancements in medical devices and pharmaceuticals.
• Product Performance & Market Positioning: Analyzes product performance, market positioning, and growth potential to optimize strategies.
• Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
• Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
• Market Updates & Industry Changes: Covers recent regulatory changes, new policies, and emerging technologies.
• Competitive Strategies: Analyzes competitor strategies, market share, and emerging players.
• Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
• Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
• Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
• Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
• Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
• Post-market Surveillance: Uses post-market data to enhance product safety and access.
• Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

The global uterine manipulation devices market report delivers a detailed analysis with 62 key tables, more than 54 visually impactful figures, and 158 pages of expert insights, providing a complete view of the market landscape.

Target Audience 2024

• Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
• Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
• Technology & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
• Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
• Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
• Supply Chain: Distribution and Supply Chain Managers.
• Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
• Academic & Research: Academic Institutions.